KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Gross Margin (2017 - 2025)

Guardant Health's Gross Margin history spans 8 years, with the latest figure at 100.81% for Q4 2025.

  • For Q4 2025, Gross Margin rose 5272.0% year-over-year to 100.81%; the TTM value through Dec 2025 reached 64.46%, up 1384.0%, while the annual FY2025 figure was 64.46%, 1384.0% up from the prior year.
  • Gross Margin for Q4 2025 was 100.81% at Guardant Health, up from 51.97% in the prior quarter.
  • Across five years, Gross Margin topped out at 272.12% in Q4 2022 and bottomed at 31.54% in Q3 2022.
  • The 5-year median for Gross Margin is 48.81% (2024), against an average of 69.3%.
  • The largest annual shift saw Gross Margin surged 16231bps in 2021 before it plummeted -22315bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 222.36% in 2021, then increased by 22bps to 272.12% in 2022, then plummeted by -82bps to 48.97% in 2023, then dropped by -2bps to 48.09% in 2024, then soared by 110bps to 100.81% in 2025.
  • Per Business Quant, the three most recent readings for GH's Gross Margin are 100.81% (Q4 2025), 51.97% (Q3 2025), and 48.47% (Q2 2025).